⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14175014 | 1.00 | — | — | |
| SCHEMBL698664 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL20605479 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL631154 | 0.97 | — | — | |
| SCHEMBL26622824 | 0.82 | KDM4E (0.32) | — | |
| SCHEMBL235759 | 0.81 | KDM4E (0.36) | — | |
| SCHEMBL317785 | 0.81 | KDM4E (0.36) | — | |
| SCHEMBL516493 | 0.79 | TSHR (0.32) | — | |
| SCHEMBL12779438 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL10694337 | 0.77 | KDM4E (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116635396-A | Pt (IV) chemotherapeutic prodrugs and their controlled release for treating tumors | 北京大学 | 2023-08-22 | — | — | CN | claimed |
| CN-108369907-B | Liquid composition and method for surface treatment of semiconductor substrate using same | 三菱瓦斯化学株式会社 | 2022-09-20 | — | — | CN | claimed |
| US-11094526-B2 | Liquid composition for imparting alcohol-repellency to semiconductor substrate material, and method for treating surface of semiconductor substrate using said liquid composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-08-17 | — | — | US | claimed |
| EP-3404700-B1 | LIQUID COMPOSITION FOR IMPARTING ALCOHOL-REPELLENCY TO SEMICONDUCTOR SUBSTRATE MATERIAL, AND METHOD FOR TREATING SURFACE OF SEMICONDUCTOR SUBSTRATE USING SAID LIQUID COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2020-05-13 | — | — | EP | claimed |
| US-20190019672-A1 | LIQUID COMPOSITION FOR IMPARTING ALCOHOL-REPELLENCY TO SEMICONDUCTOR SUBSTRATE MATERIAL, AND METHOD FOR TREATING SURFACE OF SEMICONDUCTOR SUBSTRATE USING SAID LIQUID COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2019-01-17 | — | — | US | claimed |
| EP-3404700-A1 | LIQUID COMPOSITION FOR IMPARTING ALCOHOL-REPELLENCY TO SEMICONDUCTOR SUBSTRATE MATERIAL, AND METHOD FOR TREATING SURFACE OF SEMICONDUCTOR SUBSTRATE USING SAID LIQUID COMPOSITION | Mitsubishi Gas Chemical Company, Inc. (JP) | 2018-11-21 | — | — | EP | claimed |
| CN-103814016-B | Compositions and methods for producing pyrimidine and pyridine compounds having BTK inhibitory activity | 默克专利有限公司 | 2017-03-08 | — | — | CN | claimed |
| CN-102933578-B | Cyano-quinoline derivatives | 天津和美生物技术有限公司 | 2016-09-07 | — | — | CN | claimed |
| CN-104245701-A | Combination with tyrosine kinase inhibitors and use thereof | NOVARTIS AG | 2014-12-24 | — | — | CN | claimed |
| CN-101600701-A | Arylsulfonamide derivatives and methods of use thereof | WYETH CORP (US) | 2009-12-09 | — | — | CN | claimed |
| EP-2061776-A1 | ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | Wyeth a Corporation of the State of Delaware (US) | 2009-05-27 | — | — | EP | claimed |
| WO-2008073459-A1 | ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-06-19 | — | — | WO | claimed |
| US-20040234492-A1 | contacting the wood with a wood preserving aqueous emulsion containing anionic and cationic biocides that form complexes; nontoxic, synergistic, free of heavy metals | BRIDGEWATER INTELLECTUAL PROPERTIES LLC | 2004-11-25 | — | — | US | claimed |
| EP-0089749-B2 | Composition and process for the dyeing of hair | BRISTOL MYERS SQUIBB CO (US) | 1993-11-10 | — | — | EP | claimed |
| US-4094699-A | Process for converting premilled quinacridone to pigmentary form | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-06-13 | — | — | US | claimed |
| EP-4519265-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | Bayer Aktiengesellschaft (DE) | 2025-03-12 | — | — | EP | disclosed |
| WO-2024229019-A8 | POLYMORPHIC FORMS OF (E)-1-((10S)-4-((4-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN- 7-YLOXY)-2-FLUORO-5-METHYLPHENYL)AMINO)-7,8,10,11-TETRAHYDRO- 9H-6,10-METHANOPYRIMIDO[4',5':5,6]PYRIDO[3,2-B][1,4,7]OXADIAZONIN-9- YL)-4-(DIMETHYLAMINO)BUT-2-EN-1-ONE | ENLIVEN INC. (US) | 2025-01-02 | — | — | WO | disclosed |
| US-3961042-A | BACTERICIDES | MILLMASTER ONYX CORPORATION (US) | 1976-06-01 | — | — | US | disclosed |
| US-3933812-A | ANTIMICROBIAL QUATERNARY AMMONIUM COPOLYMERS | MILLMASTER ONYX CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
| US-3932664-A | Substituted phenoxyalkyl quaternary ammonium compounds as antiarrhythemic agents | THE DOW CHEMICAL COMPANY (US) | 1976-01-13 | — | — | US | disclosed |